Hitchin, United Kingdom

Stephen Carl McKeown

USPTO Granted Patents = 6 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Hitchin, GB (2010 - 2015)
  • Horsham, GB (2017)

Company Filing History:


Years Active: 2010-2017

where 'Filed Patents' based on already Granted Patents

6 patents (USPTO):

Title: Innovations of Stephen Carl McKeown

Introduction

Stephen Carl McKeown is a notable inventor based in Hitchin, GB. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that activate the IP receptor. With a total of six patents to his name, McKeown's work has the potential to impact the treatment of various diseases.

Latest Patents

One of McKeown's latest patents involves IP receptor agonist heterocyclic compounds. This invention provides heterocyclic derivatives that activate the IP receptor, which is useful in treating pulmonary arterial hypertension (PAH), pulmonary fibrosis, and other fibrotic conditions. Additionally, he has developed salts of 7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid as IP receptor agonists. These salts are beneficial for treating diseases influenced by the activation of the IP receptor and include pharmaceutical compositions that contain these salts.

Career Highlights

Throughout his career, McKeown has worked with prominent companies such as Novartis AG and GlaxoSmithKline LLC. His experience in these organizations has allowed him to refine his expertise in pharmaceutical research and development.

Collaborations

Some of McKeown's notable coworkers include Steven John Charlton and Catherine Leblanc. Their collaborative efforts have contributed to the advancement of innovative solutions in the pharmaceutical industry.

Conclusion

Stephen Carl McKeown's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…